SHYNDEC: Maleate Enalapril Tablets pass consistency evaluation
I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, SHYNDEC announced that the company has received the "Drug Supplement Application Approval Notice" issued by the National Medical Products Administration, approving the Enalapril Maleate Tablets (5mg) to pass the consistency evaluation of generic drug quality and efficacy. Enalapril Maleate Tablets are an angiotensin-converting enzyme inhibitor primarily used to treat primary hypertension, renovascular hypertension, and symptomatic heart failure
According to the Zhitong Finance APP, SHYNDEC (600420.SH) announced that the company has received the "Drug Supplement Application Approval Notice" issued by the National Medical Products Administration, approving the Enalapril Maleate Tablets (5mg) to pass the consistency evaluation of quality and efficacy for generic drugs. Enalapril Maleate Tablets are an angiotensin-converting enzyme inhibitor primarily used to treat primary hypertension, renal vascular hypertension, and symptomatic heart failure